Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level
In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC
NCI Programs: BSA Approves Formation Of Two Grant Programs:
Molecular target Drug Discovery Grants; Unanimously Approved
Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote
DO RFAs cut Into R01 Grant Pool? Board Asks
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









